ATE431357T1 - Modulatoren der funktion des fas rezeptors und anderer proteine - Google Patents

Modulatoren der funktion des fas rezeptors und anderer proteine

Info

Publication number
ATE431357T1
ATE431357T1 AT96919472T AT96919472T ATE431357T1 AT E431357 T1 ATE431357 T1 AT E431357T1 AT 96919472 T AT96919472 T AT 96919472T AT 96919472 T AT96919472 T AT 96919472T AT E431357 T1 ATE431357 T1 AT E431357T1
Authority
AT
Austria
Prior art keywords
receptor
fas receptor
proteins
modulators
function
Prior art date
Application number
AT96919472T
Other languages
English (en)
Inventor
David Wallach
Mark Boldin
Tanya Goncharov
Yury Goltsev
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL11498695A external-priority patent/IL114986A0/xx
Priority claimed from IL11531995A external-priority patent/IL115319A0/xx
Priority claimed from IL11658895A external-priority patent/IL116588A0/xx
Priority claimed from IL11793296A external-priority patent/IL117932A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE431357T1 publication Critical patent/ATE431357T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Holo Graphy (AREA)
  • Peptides Or Proteins (AREA)
AT96919472T 1995-07-16 1996-06-14 Modulatoren der funktion des fas rezeptors und anderer proteine ATE431357T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IL11461595A IL114615A0 (en) 1995-07-16 1995-07-16 Modulators of the function of fas receptors and other proteins
IL11498695A IL114986A0 (en) 1995-08-17 1995-08-17 Modulators of the function of fas receptors and other proteins
IL11531995A IL115319A0 (en) 1995-09-14 1995-09-14 Modulators of the function of fas receptors and other proteins
IL11658895A IL116588A0 (en) 1995-12-27 1995-12-27 Modulators of the function of fas receptors and other proteins
IL11793296A IL117932A0 (en) 1996-04-16 1996-04-16 Modulators of the function of FAS receptors and other proteins
PCT/US1996/010521 WO1997003998A1 (en) 1995-07-16 1996-06-14 Modulators of the function of fas receptors and other proteins

Publications (1)

Publication Number Publication Date
ATE431357T1 true ATE431357T1 (de) 2009-05-15

Family

ID=27517674

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96919472T ATE431357T1 (de) 1995-07-16 1996-06-14 Modulatoren der funktion des fas rezeptors und anderer proteine

Country Status (17)

Country Link
US (3) US6586571B1 (de)
EP (2) EP0914325B1 (de)
JP (1) JP3980641B2 (de)
KR (1) KR100491095B1 (de)
CN (1) CN100390195C (de)
AT (1) ATE431357T1 (de)
AU (1) AU708799B2 (de)
CA (1) CA2226973C (de)
DE (1) DE69637931D1 (de)
DK (2) DK2042509T3 (de)
ES (2) ES2326704T3 (de)
IL (1) IL114615A0 (de)
MX (1) MX9800537A (de)
NO (1) NO321092B1 (de)
PT (2) PT914325E (de)
SI (2) SI2042509T1 (de)
WO (1) WO1997003998A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712381A (en) * 1994-10-19 1998-01-27 Genetics Institute, Inc. MADD, a TNF receptor death domain ligand protein
US6015665A (en) * 1995-02-13 2000-01-18 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6060238A (en) * 1995-02-13 2000-05-09 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US7097972B1 (en) 1995-02-13 2006-08-29 Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
US7807783B1 (en) 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US5976822A (en) * 1995-05-18 1999-11-02 Coulter International Corp. Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis
US5786173A (en) * 1996-03-19 1998-07-28 Idun Pharmaceuticals, Inc. MCH4 and MCH5, apoptotic protease, nucleic acids encoding and methods of use
US5712115A (en) * 1996-03-19 1998-01-27 Incyte Pharmaceuticals, Inc. Human cell death-associated protein
US6008042A (en) * 1996-05-16 1999-12-28 Smithkline Beecham Corporation Interleukin-1 beta converting enzyme like apoptotic protease-7
US5932694A (en) * 1996-06-24 1999-08-03 Ludwig Institute For Cancer Research Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof
EP0842665A3 (de) * 1996-11-14 2002-12-18 Smithkline Beecham Corporation Interleukin-1-beta-konvertierendes-Enzym-ähnliche Apoptosisproteasen und ihre Agonisten
US5932425A (en) * 1997-02-18 1999-08-03 Signal Pharmaceuticals, Inc. Compositions and methods for modulating cellular NF-κB activation
IL120759A0 (en) 1997-03-03 1997-09-30 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US20040230039A1 (en) 1997-03-01 2004-11-18 Yeda Research And Development Co., Ltd. Cash (caspase homologue) with death effector domain, modulators of the function of FAS receptors
KR20010014218A (ko) 1997-06-27 2001-02-26 오노 야꾸힝 고교 가부시키가이샤 신규의 리포터 유전자 ｄｎａ를 포함하는 플라스미드ｄｎａ 및 그 용도
JPH1175859A (ja) * 1997-09-08 1999-03-23 R P R Jienseru Kk アポト−シス関連遺伝子発現性のウイルスベクター系
WO1999041398A1 (en) * 1998-02-11 1999-08-19 Genvec, Inc. Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
US6207458B1 (en) * 1998-05-07 2001-03-27 University Of Washigton/Stowers Insitute For Medical Research Proteins capable of regulating NF-κB JNK and apoptosis pathways and methods of using the same
US6759041B1 (en) 1998-05-29 2004-07-06 Mochida Pharmaceutical Co., Ltd. Preventives/remedies for autoimmune demyelinating diseases
AU5205499A (en) 1998-07-27 2000-02-21 Pharmacia & Upjohn Company Method for autoactivation of procaspase 8
US7052834B1 (en) 1998-12-31 2006-05-30 St. Jude Children's Research Hospital Tumor suppressor protein involved in death signaling, and diagnostics, therapeutics, and screening based on this protein
WO2000039347A1 (en) * 1998-12-31 2000-07-06 St. Jude Children's Research Hospital A tumor suppressor protein involved in death signaling, and diagnostics, therapeutics, and screening based on this protein
US8809002B2 (en) * 2008-07-10 2014-08-19 Dana-Farber Cancer Institute, Inc. MUC1, caspase-8, and DED-containing proteins
KR102613549B1 (ko) * 2021-03-12 2023-12-13 씨제이제일제당 주식회사 신규 세린 프로테아제 변이체

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4588585A (en) 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (de) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimäre Rezeptoren durch Verbindung und Expression von DNS
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US4699880A (en) 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
IL73883A (en) 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
US5116943A (en) 1985-01-18 1992-05-26 Cetus Corporation Oxidation-resistant muteins of Il-2 and other protein
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4766067A (en) 1985-05-31 1988-08-23 President And Fellows Of Harvard College Gene amplification
JPS63501765A (ja) 1985-11-01 1988-07-21 インタ−ナショナル、ジェネティック、エンジニアリング　インコ−ポレ−テッド 抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途
US5017691A (en) 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US4879111A (en) 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US4921794A (en) 1987-01-14 1990-05-01 President And Fellows Of Harvard College T7 DNA polymerase
US4795699A (en) 1987-01-14 1989-01-03 President And Fellows Of Harvard College T7 DNA polymerase
IL83878A (en) 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4904584A (en) 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US5149782A (en) 1988-08-19 1992-09-22 Tanox Biosystems, Inc. Molecular conjugates containing cell membrane-blending agents
US5000000A (en) * 1988-08-31 1991-03-19 University Of Florida Ethanol production by Escherichia coli strains co-expressing Zymomonas PDC and ADH genes
IL94039A (en) 1989-08-06 2006-09-05 Yeda Res & Dev Antibodies to tbp - 1 and their use
US5091310A (en) 1988-09-23 1992-02-25 Cetus Corporation Structure-independent dna amplification by the polymerase chain reaction
US5066584A (en) 1988-09-23 1991-11-19 Cetus Corporation Methods for generating single stranded dna by the polymerase chain reaction
US5142033A (en) 1988-09-23 1992-08-25 Hoffmann-La Roche Inc. Structure-independent DNA amplification by the polymerase chain reaction
US4994370A (en) 1989-01-03 1991-02-19 The United States Of America As Represented By The Department Of Health And Human Services DNA amplification technique
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
ES2072330T5 (es) 1989-05-18 2013-06-24 Yeda Research And Development Co., Ltd. Proteínas de unión II al Factor de Necrosis Tumoral, su purificación y anticuerpos frente a los mismos
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
IL101769A (en) 1992-05-03 2007-02-11 Yeda Res & Dev Modulation of TNF receptor action
IL104355A (en) 1993-01-10 2006-08-20 Yeda Res & Dev Tnf receptor promoter
IL109633A (en) 1994-05-11 2005-05-17 Yeda Res & Dev Tnf receptor promoter
IL111125A0 (en) * 1994-05-11 1994-12-29 Yeda Res & Dev Soluble oligomeric tnf/ngf super family ligand receptors and their use
US6538121B1 (en) * 1994-11-01 2003-03-25 Human Genome Sciences, Inc. Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
DE69535634T2 (de) * 1994-12-15 2008-08-28 Yeda Research And Development Co., Ltd. Modulatoren der funktion des fas/ap01 rezeptors
AU5133296A (en) * 1995-02-22 1996-09-11 Yeda Research And Development Co. Ltd. Modulators of regulatory proteins
PT813419E (pt) * 1995-02-22 2005-09-30 Yeda Res & Dev Moduladores de proteinas reguladoras
US7807783B1 (en) * 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US5712115A (en) 1996-03-19 1998-01-27 Incyte Pharmaceuticals, Inc. Human cell death-associated protein
US5786173A (en) 1996-03-19 1998-07-28 Idun Pharmaceuticals, Inc. MCH4 and MCH5, apoptotic protease, nucleic acids encoding and methods of use
US6008042A (en) * 1996-05-16 1999-12-28 Smithkline Beecham Corporation Interleukin-1 beta converting enzyme like apoptotic protease-7
AU6162496A (en) 1996-06-05 1998-01-05 Human Genome Sciences, Inc. Interleukin-1 beta converting enzyme like apoptotic protease-7
US5837837A (en) 1997-02-27 1998-11-17 Millennium Pharmaceuticals, Inc. Nucleic acids molecules encoding Caspase-8h and Caspase-8i
DE19713393C2 (de) 1997-04-01 2002-12-05 Apotech Res & Dev Ltd Flip-Gen und Flip-Protein

Also Published As

Publication number Publication date
DK0914325T3 (da) 2009-08-17
WO1997003998A9 (en) 2002-03-14
NO980198D0 (no) 1998-01-15
KR19990029051A (ko) 1999-04-15
CA2226973C (en) 2012-01-03
WO1997003998A1 (en) 1997-02-06
EP2042509B1 (de) 2013-02-20
ES2326704T3 (es) 2009-10-16
US7799901B2 (en) 2010-09-21
CN100390195C (zh) 2008-05-28
NO321092B1 (no) 2006-03-13
EP0914325A1 (de) 1999-05-12
EP0914325B1 (de) 2009-05-13
EP0914325A4 (de) 2001-07-25
CA2226973A1 (en) 1997-02-06
IL114615A0 (en) 1995-11-27
US20030219411A1 (en) 2003-11-27
DE69637931D1 (de) 2009-06-25
SI2042509T1 (sl) 2013-04-30
JPH11509422A (ja) 1999-08-24
KR100491095B1 (ko) 2005-12-19
CN1198165A (zh) 1998-11-04
PT2042509E (pt) 2013-03-11
US20070154905A1 (en) 2007-07-05
JP3980641B2 (ja) 2007-09-26
ES2405657T3 (es) 2013-05-31
AU708799B2 (en) 1999-08-12
AU6180596A (en) 1997-02-18
DK2042509T3 (da) 2013-03-11
US6586571B1 (en) 2003-07-01
EP2042509A1 (de) 2009-04-01
PT914325E (pt) 2009-07-20
MX9800537A (es) 1998-05-31
SI0914325T1 (sl) 2009-10-31
HK1016990A1 (zh) 1999-11-12
NO980198L (no) 1998-03-09

Similar Documents

Publication Publication Date Title
DE69637931D1 (de) Modulatoren der funktion des fas rezeptors und anderer proteine
WO2000031124A3 (en) Peptides that modulate the interaction of b class ephrins and pdz domains
PT724456E (pt) Anticorpos contra cd4
ATE309347T1 (de) Protocadherin-proteine und verwendungen davon
FI960809L (fi) Hermoregeneraatio käyttäen ihmisen luun morfogeneettisiä proteiineja
ATE198768T1 (de) Von l protein abgeleitete immunoglobulin-bindende proteine und deren anwendungen
DE19882126T1 (de) Hydrierung von Kohlenwasserstoffen
EP1097162A4 (de) Oligonukleotide mit für bindungstaschen spezifischen chiralen phosphorothioat-internukleosidbindungen
PT813419E (pt) Moduladores de proteinas reguladoras
MXPA03003207A (es) Materiales y metodos para modular la actividad de union de ligando/enzimatica de proteinas alfa/¦ que contienen un sitio regulador alosterico.
DK0760851T3 (da) Tumor-nekrose-faktor receptor-associeret-faktor
WO1998034954A3 (en) Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
NO901212D0 (no) Intracellulaere adhesjonsmolekyler og deres bindingsligander.
EA199900794A1 (ru) Cash (гомолог каспазы) с "гибель-эффекторным" доменом, модуляторы функций fas-рецепторов
WO2001058954A3 (en) Trade molecules and uses related thereto
NO900545L (no) Krydder.
ATE218619T1 (de) Genetische selektion von zur ligandenbindung befähigten proteinen mittels signaltransduktion in mikroorganismen
WO1996023883A3 (en) Modified ligands for receptor tyrosine kinases
DE69009824D1 (de) Pyrimidin-Derivat und dieses enthaltende Flüssigkristall-Zusammensetzung.
ATE171373T1 (de) Lysin salz von 6-fluoro-3,2-(2-thenoyl)-2-oxidol- 1-carboxamid
DK1007672T3 (da) Intracellulære glucocorticoid inducerede leucin zippermodulatorer af apoptotiske celledödsforlöb
RU2000106030A (ru) Способ воздействия на связывание p53 с геном-мишенью
DE69836226D1 (de) Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
IT8884110A0 (it) Il libro dei libri.
NO902311D0 (no) Intracellulaere adhesjonsmolekyler og deres bindingsligander.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0914325

Country of ref document: EP